225 related articles for article (PubMed ID: 35203447)
1. Profiling Microglia in a Mouse Model of Machado-Joseph Disease.
Campos AB; Duarte-Silva S; Fernandes B; das Neves SP; Marques F; Teixeira-Castro A; Neves-Carvalho A; Monteiro-Fernandes D; Portugal CC; Socodato R; Summavielle T; Ambrósio AF; Relvas JB; Maciel P
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203447
[TBL] [Abstract][Full Text] [Related]
2. Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado-Joseph Disease.
Campos AB; Duarte-Silva S; Fernandes B; Coimbra B; Campos J; Monteiro-Fernandes D; Teixeira-Castro A; Ambrósio AF; Maciel P
Cells; 2022 Jun; 11(13):. PubMed ID: 35805106
[TBL] [Abstract][Full Text] [Related]
3. RNA Interference Therapy for Machado-Joseph Disease: Long-Term Safety Profile of Lentiviral Vectors Encoding Short Hairpin RNAs Targeting Mutant Ataxin-3.
Nóbrega C; Codêsso JM; Mendonça L; Pereira de Almeida L
Hum Gene Ther; 2019 Jul; 30(7):841-854. PubMed ID: 30760052
[TBL] [Abstract][Full Text] [Related]
4. Association between Machado-Joseph disease and oxidative stress biomarkers.
Pacheco LS; da Silveira AF; Trott A; Houenou LJ; Algarve TD; Belló C; Lenz AF; Mânica-Cattani MF; da Cruz IB
Mutat Res Genet Toxicol Environ Mutagen; 2013 Oct; 757(2):99-103. PubMed ID: 23994570
[TBL] [Abstract][Full Text] [Related]
5. The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples.
Duarte Lobo D; Nobre RJ; Oliveira Miranda C; Pereira D; Castelhano J; Sereno J; Koeppen A; Castelo-Branco M; Pereira de Almeida L
Acta Neuropathol Commun; 2020 Aug; 8(1):152. PubMed ID: 32867861
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Therapies for Machado-Joseph Disease.
Duarte-Silva S; Maciel P
Adv Exp Med Biol; 2018; 1049():369-394. PubMed ID: 29427114
[TBL] [Abstract][Full Text] [Related]
7. Trehalose alleviates the phenotype of Machado-Joseph disease mouse models.
Santana MM; Paixão S; Cunha-Santos J; Silva TP; Trevino-Garcia A; Gaspar LS; Nóbrega C; Nobre RJ; Cavadas C; Greif H; Pereira de Almeida L
J Transl Med; 2020 Apr; 18(1):161. PubMed ID: 32272938
[TBL] [Abstract][Full Text] [Related]
8. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
9. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.
Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L
Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575
[TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis.
Nóbrega C; Simões AT; Duarte-Neves J; Duarte S; Vasconcelos-Ferreira A; Cunha-Santos J; Pereira D; Santana M; Cavadas C; de Almeida LP
Adv Exp Med Biol; 2018; 1049():349-367. PubMed ID: 29427113
[TBL] [Abstract][Full Text] [Related]
11. Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease.
Esteves S; Duarte-Silva S; Naia L; Neves-Carvalho A; Teixeira-Castro A; Rego AC; Silva-Fernandes A; Maciel P
PLoS One; 2015; 10(10):e0141610. PubMed ID: 26505994
[TBL] [Abstract][Full Text] [Related]
12. Protective roles of carbonic anhydrase 8 in Machado-Joseph Disease.
Hsieh M; Hsieh BY; Ma CY; Li YT; Liu CS; Lo CM
J Neurosci Res; 2019 Oct; 97(10):1278-1297. PubMed ID: 31157458
[TBL] [Abstract][Full Text] [Related]
13. Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.
Watchon M; Yuan KC; Mackovski N; Svahn AJ; Cole NJ; Goldsbury C; Rinkwitz S; Becker TS; Nicholson GA; Laird AS
J Neurosci; 2017 Aug; 37(32):7782-7794. PubMed ID: 28687604
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease.
Duarte-Neves J; Gonçalves N; Cunha-Santos J; Simões AT; den Dunnen WF; Hirai H; Kügler S; Cavadas C; Pereira de Almeida L
Hum Mol Genet; 2015 Oct; 24(19):5451-63. PubMed ID: 26220979
[TBL] [Abstract][Full Text] [Related]
15. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
Gonçalves N; Simões AT; Cunha RA; de Almeida LP
Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556
[TBL] [Abstract][Full Text] [Related]
16. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
Alves S; Régulier E; Nascimento-Ferreira I; Hassig R; Dufour N; Koeppen A; Carvalho AL; Simões S; de Lima MC; Brouillet E; Gould VC; Déglon N; de Almeida LP
Hum Mol Genet; 2008 Jul; 17(14):2071-83. PubMed ID: 18385100
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy with m-TOR-dependent and -independent autophagy inducers causes neurotoxicity in a mouse model of Machado-Joseph disease.
Duarte-Silva S; Silva-Fernandes A; Neves-Carvalho A; Soares-Cunha C; Teixeira-Castro A; Maciel P
Neuroscience; 2016 Jan; 313():162-73. PubMed ID: 26601773
[TBL] [Abstract][Full Text] [Related]
18. Selection of Reference Genes for Normalization of Gene Expression Data in Blood of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3 (MJD/SCA3) Subjects.
Ferreira AF; Raposo M; Vasconcelos J; Costa MDC; Lima M
J Mol Neurosci; 2019 Nov; 69(3):450-455. PubMed ID: 31286408
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of autophagy in postmortem brains of Machado-Joseph disease patients.
Sittler A; Muriel MP; Marinello M; Brice A; den Dunnen W; Alves S
Neuropathology; 2018 Apr; 38(2):113-124. PubMed ID: 29218765
[TBL] [Abstract][Full Text] [Related]
20. Ibuprofen enhances synaptic function and neural progenitors proliferation markers and improves neuropathology and motor coordination in Machado-Joseph disease models.
Mendonça LS; Nóbrega C; Tavino S; Brinkhaus M; Matos C; Tomé S; Moreira R; Henriques D; Kaspar BK; Pereira de Almeida L
Hum Mol Genet; 2019 Nov; 28(22):3691-3703. PubMed ID: 31127937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
